Home » Topics » Regulatory

Regulatory
RSS

FDA approves Gemzar for first-line treatment of non-small cell lung cancer

Sep. 4, 1998

Nolvadex recommended for approval in U.S., to be copromoted by Zeneca and Roche

Sep. 3, 1998

Lamotrigine approved for new indication in the U.S.: Lennox-Gastaut syndrome

Sep. 2, 1998

FDA approves first vaccine for prevention of rotaviral disease

Sep. 1, 1998

FDA grants first approval for an antisense drug

Aug. 31, 1998

Canadian authorities approve use of Fragmin in treatment of heart disease

Aug. 31, 1998

Hoechst Marion Roussel and 3M file NDA for QVAR

Aug. 28, 1998

CIBIS-II study results confirm benefits of beta-blockade in heart failure

Aug. 27, 1998

FDA approves first treatment for Crohn's disease

Aug. 27, 1998

MOXCON study will test the efficacy of SIRAs in treating heart failure

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...